Browsing Tag
Pacira BioSciences
3 posts
How the NOPAIN Act could support broader reimbursement momentum for EXPAREL
Could the NOPAIN Act accelerate EXPAREL adoption in outpatient orthopedic surgery? Explore the reimbursement and opioid-reduction implications.
Can ATX101 disrupt the multibillion-dollar post-surgical pain market?
Can Allay Therapeutics’ ATX101 replace opioids in post-surgical care? Read how this long-acting bupivacaine platform may disrupt the pain relief market by 2026.
Pacira BioSciences strengthens gene therapy pipeline with GQ Bio takeover
Pacira BioSciences, Inc. has taken a significant step toward expanding its presence in genetic medicine by acquiring the…